The Mediterranean Diet has shown to be beneficial in reducing the incidence of Type 2 Diabetes Mellitus in elderly patients. The PREDIMED (Prevención con Dieta Mediterránea) cardiovascular prevention trial was a multicenter trial in Spain involving 3,451 participants, aged 55-80 years old, who were randomized into three groups: a Mediterranean diet supplemented with extra virgin olive oil (EVOO), a Mediterranean diet supplemented with mixed nuts, or a control diet low in fats. The participants were asked not to increase their physical activity and were also given food advice from dieticians on which foods to eat. Median 4.1 years follow-up showed people eating a Mediterranean diet supplemented with EVOO had a relative reduction of 40% in diabetes risk compared with the control group, while people eating a Mediterranean diet supplemented with mixed nuts had a relative reduction of 18%. How often do you discuss Mediterranean diet with your patients? What other chronic conditions benefit from the Mediterranean diet based on the recent research?
For additional information, please see JAMA.
Image Courtesy of [Serge Bertasius Photography]/FreeDigitalPhotos.net
A recent randomized trial published in the Journal of the American Medical Association examined the association between Mediterranean diet and the incidence of symptomatic peripheral artery disease (PAD). Patients were randomly selected to participate in one of the following groups: a Mediterranean diet high in extra-virgin olive oil; a Mediterranean diet high in nuts; or a low-fat diet. The results of the study found that both Mediterranean diet groups had a significantly lower occurrence of PAD compared to the low-fat diet group and no significant difference was found between the two intervention groups. How often do you recommend Mediterranean diet to your patients?
For additional information, please click JAMA.
Image courtesy of [luigi diamanti]/FreeDigitalPhotos.net.